Orchestra BioMed Holdings, Inc. Ordinary Shares Share Price
NASDAQ: OBIO | Micro CapOrchestra BioMed Holdings, Inc. Ordinary Shares Stock Performance
Open $4.20 | Prev. Close $4.14 | Circuit Range N/A |
Day Range $4.20 - $4.28 | Year Range $2.21 - $5.40 | Volume 6,842 |
Average Traded $4.23 |
Orchestra BioMed Holdings, Inc. Ordinary Shares Share Price Today
As of 10 August 2026, Orchestra BioMed Holdings, Inc. Ordinary Shares's share price is $4.22. The stock opened at $4.20, compared to its previous close of $4.14. During today's trading session, Orchestra BioMed Holdings, Inc. Ordinary Shares's share price traded between $4.20 and $4.28, with an average price of $4.24. Over the past 52 weeks, the stock has recorded a high of $5.40 and a low of $2.21. In terms of performance, Orchestra BioMed Holdings, Inc. Ordinary Shares's share price has declined by 3.65% over the last six months and is up 54.01% on a year-on-year basis.
Orchestra BioMed Holdings, Inc. Ordinary Shares Share Price Chart
Orchestra BioMed Holdings, Inc. Ordinary Shares Stock Fundamentals & Key Indicators
Market Cap $201.49M | PE Ratio (TTM) -3.80 | Dividend Yield N/A |
EPS (TTM) $-1.11 | Revenue (TTM) $33.48M | Return On Equity (TTM) -98.38% |
Profit Margin -157.40% | Debt to Equity 0.31 | Quarterly Earnings Growth YoY -35.02% |
Orchestra BioMed Holdings, Inc. Ordinary Shares Quarterly Profit & Loss
All figures in USD
Orchestra BioMed Holdings, Inc. Ordinary Shares Annual Profit & Loss
All figures in USD
About Orchestra BioMed Holdings, Inc. Ordinary Shares
Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States. The company's flagship product candidates include Atrioventricular Interval Modulation, a bioelectronic therapy candidate designed to immediately, substantially, and persistently lower blood pressure; and Virtue Sirolimus AngioInfusion Balloon for the treatment of atherosclerotic artery disease. It also develops Cardiac Neuromodulation Therapy for heart failure, or potential treatment of clinical indications; and CNT-HF, a bioelectronic product candidate that aims to reduce chronic sympathetic nervous system activity in heart failure. In addition, the company offers FreeHold devices and additional minimally invasive surgery enabling devices; and Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and upper gastrointestinal endoscopy procedures. It has a collaboration agreement with Medtronic, Inc. for the development of AVIM therapy for the treatment of HTN in pacemaker-indicated patients; and a strategic collaboration with Terumo Corporation and Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral artery disease. Orchestra BioMed Holdings, Inc. was founded in 2018 and is headquartered in New Hope, Pennsylvania.
Orchestra BioMed Holdings, Inc. Ordinary Shares Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $4.08 | $4.26 | +7.44% |
Jul 2026 | $4.32 | $3.96 | -8.22% |
Jun 2026 | $3.90 | $4.32 | +11.05% |
May 2026 | $3.98 | $3.89 | -2.38% |
Apr 2026 | $4.43 | $3.98 | -6.57% |
Mar 2026 | $4.27 | $4.26 | -2.63% |
Feb 2026 | $3.71 | $4.38 | +25.14% |
Jan 2026 | $4.25 | $3.50 | -15.46% |
Dec 2025 | $5.29 | $4.14 | -22.18% |
Nov 2025 | $3.92 | $5.32 | +36.06% |
Oct 2025 | $2.49 | $3.91 | +57.98% |
Sep 2025 | $2.71 | $2.48 | -9.67% |
OBIO Share Price FAQs
What is Orchestra BioMed Holdings, Inc. Ordinary Shares share price today?
What is the 52 week high and 52 week low of Orchestra BioMed Holdings, Inc. Ordinary Shares stock?
What is OBIO's market capitalisation today?
What is OBIO's net income for the last quarter?
What is the 5 year returns of OBIO?
What is the high & low stock price of OBIO today?
Can I buy OBIO shares in India?